Crosslink Capital Inc - Nov 11, 2021 Form 4 Insider Report for Weave Communications, Inc. (WEAV)

Role
10%+ Owner
Signature
Maureen Offer, Chief Financial Officer of Crosslink Capital, Inc.
Stock symbol
WEAV
Transactions as of
Nov 11, 2021
Transactions value $
$9,600,000
Form type
4
Date filed
11/15/2021, 06:34 PM
Previous filing
Nov 10, 2021
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WEAV Common Stock Purchase $9.6M +400K +32.69% $24.00 1.62M Nov 11, 2021 See Note 1 F1
transaction WEAV Common Stock Conversion of derivative security $0 +7.25M +446.77% $0.00 8.88M Nov 15, 2021 See Note 3 F2, F3
holding WEAV Common Stock 712K Nov 11, 2021 See Note 4 F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WEAV Series B Convertible Preferred Stock Conversion of derivative security $0 -6.4M -100% $0.00* 0 Nov 15, 2021 Common Stock 6.4M $0.00 See Note 5 F2, F5
transaction WEAV Series C Convertible Preferred Stock Conversion of derivative security $0 -784K -100% $0.00* 0 Nov 15, 2021 Common Stock 784K $0.00 See Note 6 F2, F6
transaction WEAV Series D Convertible Preferred Stock Conversion of derivative security $0 -71.6K -100% $0.00* 0 Nov 15, 2021 Common Stock 71.6K $0.00 See Note 7 F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Crosslink Capital, Inc. ("Crosslink") is the investment adviser to private investment funds (the "Funds"). Certain of the Funds hold these securities directly for the benefit of their investors. These securities are beneficially owned indirectly by Crosslink as investment adviser to those Funds and by Michael J. Stark as control person of Crosslink.
F2 Shares of the Issuer's Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock converted into shares of Common Stock on a 1-for-1 basis immediately before the closing of the Issuer's initial public offering on November 15, 2021.
F3 Certain of the Funds, including Crosslink Crossover Fund VII, L.P. ("Crossover VII") and Crosslink Ventures VII, L.P. ("Ventures VII"), hold these securities directly for the benefit of their investors. These securities are beneficially owned indirectly by Crosslink as the investment adviser to those Funds and by Mr. Stark as the control person of Crosslink. Crossover VII directly holds 2,872,838 shares of Common Stock, and Crossover Fund VII Management, L.L.C. ("Crossover GP") beneficially owns those shares indirectly as the general partner of Crossover VII. Ventures VII directly holds 2,836,322 shares of Common Stock. Ventures GP beneficially owns 4,943,691 shares of Common Stock indirectly as the general partner of Ventures VII and certain other Funds.
F4 The securities are held directly by a private investment fund for the benefit of its investors. These securities are beneficially owned indirectly by Crosslink Capital Management, LLC as the investment adviser to that private investment fund.
F5 Certain of the Funds, including Crossover VII and Ventures VII, held these securities directly for the benefit of their investors. These securities were beneficially owned indirectly by Crosslink as the investment adviser to those Funds and by Mr. Stark as the control person of Crosslink. Crossover VII directly held shares of Series B Convertible Preferred Stock that were convertible into 2,559,126 shares of Common Stock, and Crossover GP beneficially owned those shares indirectly as the general partner of Crossover VII. Ventures VII directly held shares of Series B Convertible Preferred Stock that were convertible into 2,501,673 shares of Common Stock. Ventures GP beneficially owned shares of Series B Convertible Preferred Stock that were convertible into 3,838,687 shares of Common Stock indirectly as the general partner of Ventures VII and certain other Funds.
F6 Certain of the Funds, including Crossover VII and Ventures VII, held these securities directly for the benefit of their investors. These securities were beneficially owned indirectly by Crosslink as the investment adviser to those Funds and by Mr. Stark as the control person of Crosslink. Crossover VII directly held shares of Series C Convertible Preferred Stock that were convertible into 313,712 shares of Common Stock, and Crossover GP beneficially owned those shares indirectly as the general partner of Crossover VII. Ventures VII directly held shares of Series C Convertible Preferred Stock that were convertible into 306,671 shares of Common Stock. Ventures GP beneficially owned shares of Series C Convertible Preferred Stock that were convertible into 470,569 shares of Common Stock indirectly as general partner of Ventures VII and certain other Funds.
F7 Certain of the Funds, including Ventures VII, held these securities directly for the benefit of their investors. These securities were beneficially owned indirectly by Crosslink as the investment adviser to those Funds and by Mr. Stark as the control person of Crosslink. Ventures VII directly held shares of Series D Convertible Preferred Stock that were convertible into 27,978 shares of Common Stock. Ventures GP beneficially owned shares of Series D Convertible Preferred Stock that were convertible into 42,930 shares of Common Stock indirectly as general partner of Ventures VII and certain other funds.

Remarks:

The reporting persons are Crosslink Capital, Inc. ("Crosslink"), Crosslink Capital Management, LLC ("CCM"), Crosslink Crossover Fund VII, L.P. ("Crossover VII"), Crosslink Ventures VII, L.P. ("Ventures VII"), Crossover Fund VII Management, L.L.C. ("Crossover GP"), Crosslink Ventures VII Holdings, L.L.C. ("Ventures GP") and Michael J. Stark. Crosslink is the investment adviser to Crossover VII, Ventures VII and other Funds. Crossover GP is the general partner of Crossover VII. Ventures GP is the general partner or manager of Ventures VII and certain other Funds. Crosslink is filing this report on behalf of itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group. Crosslink and CCM are related entities and may constitute a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. Each other reporting person expressly disclaims membership in a group. The reporting persons disclaim beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. Following the transactions reported herein, none of Crossover VII, Ventures VII, Crossover GP or Ventures GP holds 10% or more of the Issuer's outstanding securities, and they are no longer subject to the filing requirements of section 16.